Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Jan-Erik Westlin"'
Autor:
Jacek Capala, Lars Franzén, Roger Henriksson, Annika Michanek, Sten-Åke Lindahl, A. Tommy Bergenheim, Leif G. Salford, Jan-Erik Westlin, Erik Blomquist
Publikováno v:
Radiotherapy and Oncology. 88:183-191
To evaluate the efficacy and safety of boron neutron capture therapy (BNCT) for glioblastoma multiforme (GBM) using a novel protocol for the boronophenylalanine-fructose (BPA-F) infusion.This phase II study included 30 patients, 26-69 years old, with
Autor:
Sten Nilsson, Roy H. Larsen, Gro Salberg, Jan Erik Westlin, Lise Balteskard, Kari W. Borch, Øyvind S. Bruland, Sophie D. Fosså
Publikováno v:
Clinical Cancer Research. 11:4451-4459
Purpose: The main goals were to study the safety and tolerability of the α-emitter radium-223 (223Ra) in breast and prostate cancer patients with skeletal metastases. In addition, pain palliation was evaluated. Experimental Design: Fifteen prostate
Autor:
Dan Granberg, Eva Tiensuu Janson, Britt Skogseid, Kjell Öberg, Jan-Erik Westlin, Anders Sundin
Publikováno v:
Clinical Endocrinology. 59:793-799
Summary objectives Scintigraphy with radiolabelled octreotide (octreoscan) is useful for imaging various neuroendocrine tumours, especially in patients with midgut carcinoids. We were interested in estimating the efficacy of octreoscan for detection
Autor:
Andreas Pfestroff, Jan-Erik Westlin, Rudolf Arnold, Sten Nilsson, Jin Du, Jukka Hiltunen, Ulrich Wulbrand, Marcela Márquez, Martin Feldman, Hans‐Cristophe Fehman, Anders R. Holmberg
Publikováno v:
Cancer. 94:1293-1297
BACKGROUND Somatostatin receptors (SRS, five subtypes) are expressed in a variety of human tumors, including most tumors of neuroendocrine origin, breast tumors, certain brain tumors, renal cell tumors, lymphomas, and prostate cancer. Somatostatin (S
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 46:1025-1036
Purpose: The aim of this study was to theoretically investigate how the radiation dose to cell nuclei depends on the subcellular position of 131 I. The influence of the size of the cells and crossfire irradiation in clusters of cells was also studied
Autor:
Jan-Erik Westlin, Per-Uno Malmström, Lars Gedda, Vladimir Tolmachev, Erik Blomquist, Hans Lundqvist, Åsa Liljegren, Anders Sundin, Qinghai Zhao, Anna Sjöström, Jörgen Carlsson
Publikováno v:
Acta Oncologica. 38:313-321
Conjugates with specific binding to the epidermal growth factor receptor, EGFR, of interest for radionuclide based imaging and therapy were prepared using mouse epidermal growth factor, mEGF, and dextran. In one type of conjugate, mEGF was coupled to
Autor:
Jörgen Carlsson, Hans Lundqvist, Anna Lövqvist, Anders Sundin, Jan-Erik Westlin, Harald Schneider, Vladimir Tolmachev, Mark Lubberink
Publikováno v:
Acta Oncologica. 38:343-349
Positron emission tomography (PET) is a medical imaging tool with high resolution and good quantitative properties, which makes it suitable for in vivo quantification of radioimmunotargeting agents. Most radionuclides used in radioimmunotherapy have
Autor:
Jonas Rastad, Jan-Erik Westlin, Göran Åkerström, Hampus Eklöf, Anders Elvin, Britt Skogseid, Kjell Öberg, Barbro Eriksson, Claes Juhlin, Eva Tiensuu Janson
Publikováno v:
World Journal of Surgery. 22:673-678
Radiologically demonstrable pancreatic endocrine tumors are a frequent requirement for exploration in patients with multiple endocrine neoplasia type I (MEN-I). Such delayed intervention is accompanied by a 30% to 50% incidence of pancreatic endocrin
Autor:
P.-U. Malmström, Anna Sjöström, Kenneth Wester, Jan-Erik Westlin, Anders Holmberg, Christer Busch, Peter Bue, S. Nilsson, Jörgen Carlsson
Publikováno v:
International Journal of Cancer. 76:189-193
Bladder cancers frequently exhibit an increased number of epidermal growth factor receptors (EGFR) in comparison to normal urothelium. The EGFR could potentially be a target for toxic conjugates. The aim of our study was to compare the expression of
Autor:
Anders R. Holmberg, Per-Uno Malmström, Jan-Erik Westlin, Peter Bue, Sten Nilsson, Marcela Márquez
Publikováno v:
Cancer. 80:2385-2389
The potential of radio-labelled EGF-dextran conjugates in the treatment of urinary bladder carcinoma.